{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:21:46Z","timestamp":1789647706220,"version":"4.0.0"},"reference-count":41,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nuubo Wearable Medical Technologies","award":["SEC\/FEC-INV-CLI 24-32"],"award-info":[{"award-number":["SEC\/FEC-INV-CLI 24-32"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Current guidelines recommend 24\u201348 h Holter for risk stratification and atrial fibrillation (AF) screening in hypertrophic cardiomyopathy (HCM). However, the limited duration of this approach may not provide optimal sensitivity. In addition, extended ECG monitoring has been demonstrated to be more effective in detecting arrhythmias in other clinical entities. We aimed to assess the utility of extended ECG monitoring for 30 days in a non-high-risk cohort of HCM patients. Methods: We conducted a prospective multicentre study with 113 non-high-risk HCM patients who underwent 30-day ECG monitoring with a dedicated device. We compared the detection of relevant arrhythmias (AF, atrial flutter, and non-sustained ventricular tachycardia) during 30-day monitoring with the findings observed during the first 24 h. Results: Extended ECG monitoring detected relevant arrhythmias in 63.7% of patients, compared with 12.4% during the first 24 h (p &lt; 0.001). This difference was mainly driven by non-sustained ventricular tachycardia (NSVT) (61.1% vs. 8.9%, p &lt; 0.001). Atrial fibrillation episodes were detected in 10.6% of patients after completing prolonged monitoring vs. 6.2% during the first 24 h (p = 0.066). Extended monitoring resulted in a reclassification of 21.2% of patients to a higher sudden cardiac death (SCD) risk category using the HCM-SCD calculator. Conclusions: Extended ECG monitoring significantly enhances the detection of arrhythmias in HCM. Using this technique, NSVT were detected in most patients of a non-high-risk HCM cohort. Further investigation is warranted to determine the role of extended monitoring in SCD risk stratification and AF screening.<\/jats:p>","DOI":"10.3390\/jcm14207432","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:19Z","timestamp":1761058399000},"page":"7432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extended ECG Monitoring in Patients with Hypertrophic Cardiomyopathy: The Tempo-HCM Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0466-7633","authenticated-orcid":false,"given":"Juan","family":"Caro-Cod\u00f3n","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-2004","authenticated-orcid":false,"given":"Sergio","family":"Castrej\u00f3n","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosal\u00eda","family":"Cadenas","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Infanta Sof\u00eda, San Sebasti\u00e1n de los Reyes, 38702 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-5076","authenticated-orcid":false,"given":"Carlos","family":"Casanova","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Infanta Sof\u00eda, San Sebasti\u00e1n de los Reyes, 38702 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"V\u00e9lez","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital Infanta Sof\u00eda, San Sebasti\u00e1n de los Reyes, 38702 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Basurte","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario de Navarra, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-356X","authenticated-orcid":false,"given":"Gemma","family":"Lacuey","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario de Navarra, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-1922","authenticated-orcid":false,"given":"Vicente","family":"Climent","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital General de Alicante, 03010 Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3201-1316","authenticated-orcid":false,"given":"\u00d3scar","family":"Salvador","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario de Torrej\u00f3n, Torrej\u00f3n de Ardoz, 28850 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-9656","authenticated-orcid":false,"given":"Andrea","family":"Severo-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario 12 de Octubre, Imas12, CIBER-CV, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1791-4936","authenticated-orcid":false,"given":"Luis","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Institute of Medical and Molecular Genetics, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-1473","authenticated-orcid":false,"given":"Esther","family":"P\u00e9rez-David","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Peinado","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Valbuena-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4366-7916","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Jim\u00e9nez-Mas","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario de Torrej\u00f3n, Torrej\u00f3n de Ardoz, 28850 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Moreno","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-1903","authenticated-orcid":false,"given":"Jose L.","family":"Merino","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.117.027738","article-title":"Perspectives on the Overall Risks of Living with Hypertrophic Cardiomyopathy","volume":"135","author":"Maron","year":"2017","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of Hypertrophic Cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: Systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/CIRCEP.111.962043","article-title":"Sudden Cardiac Death in Hypertrophic Cardiomyopathy","volume":"6","author":"Elliott","year":"2013","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"e533","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic Stroke and Underlying Atrial Fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial Fibrillation in Patients with Cryptogenic Stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"euad212","DOI":"10.1093\/europace\/euad212","article-title":"Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke","volume":"25","author":"Boriani","year":"2023","journal-title":"Europace"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients with Hypertrophic Cardiomyopathy","volume":"119","author":"Theuns","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jce.12982","article-title":"High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device","volume":"27","author":"Wilke","year":"2016","journal-title":"Cardiovasc. Electrophysiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","volume":"35","author":"Jichi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.117.030437","article-title":"International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)","volume":"137","author":"Jichi","year":"2018","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ijcard.2013.12.068","article-title":"Wearable wireless remote monitoring system: An alternative for prolonged electrocardiographic monitoring","volume":"172","author":"Olmos","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2017.10.063","article-title":"Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry","volume":"251","author":"Pagola","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e009796","DOI":"10.1161\/CIRCEP.120.009796","article-title":"Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score","volume":"14","author":"Carrick","year":"2021","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy","volume":"42","author":"Monserrat","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardio-myopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e004604","DOI":"10.1161\/CIRCEP.116.004604","article-title":"Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients with Hypertrophic Cardiomyopathy","volume":"10","author":"Wang","year":"2017","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","article-title":"Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study","volume":"48","author":"Maron","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","article-title":"Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Gimeno","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/eup431","article-title":"Risk stratification for sudden cardiac death in hypertrophic cardio-myopathy: Systematic review of clinical risk markers","volume":"12","author":"Christiaans","year":"2010","journal-title":"Europace"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"euad203","DOI":"10.1093\/europace\/euad203","article-title":"Risk stratification of sudden cardiac death: A review","volume":"25","author":"Garcia","year":"2023","journal-title":"Europace"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e029293","DOI":"10.1161\/JAHA.122.029293","article-title":"Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients with Hypertrophic Cardiomyopathy","volume":"12","author":"Goldstein","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.amjcard.2016.07.043","article-title":"Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients with Hypertrophic Cardiomyopathy","volume":"118","author":"Chan","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2023.04.008","article-title":"Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring","volume":"381","author":"Fumagalli","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardio-myopathy (HCM Risk-CVA)","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2023.05.021","article-title":"Risk of Left Atrial Thrombus in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation","volume":"82","author":"Burczak","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1093\/eurheartj\/ehad581","article-title":"Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines","volume":"44","author":"Wang","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/ehjci\/jead065","article-title":"Incremental significance of myocardial oedema for prognosis in hypertrophic cardiomyopathy","volume":"24","author":"Xu","year":"2023","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_35","first-page":"1791","article-title":"Variable and Limited Predictive Value of the European Society of Cardiology Hypertrophic Cardiomyopathy Sudden-Death Risk Model: A Meta-analysis","volume":"35","author":"Wang","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hrthm.2021.01.019","article-title":"Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator","volume":"18","author":"Maron","year":"2021","journal-title":"Heart Rhythm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamacardio.2021.0038","article-title":"Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial","volume":"6","author":"Gladstone","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/eurheartj\/ehz834","article-title":"Screening for atrial fibrillation: A call for evidence","volume":"41","author":"Jones","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"ref_41","unstructured":"(2022). 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J., 43, 3997\u20134126."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/20\/7432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:17:13Z","timestamp":1761059833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/20\/7432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":41,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jcm14207432"],"URL":"https:\/\/doi.org\/10.3390\/jcm14207432","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}